CuraScientific Corp.
company.status.inactiveCIK 1877788fmd_19GSDXKEHS0R3B8WC7J7BWSGY8Manufacturing · Miscellaneous Chemical ProductsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 12 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (2)
- Net income
- (5)
- Free cash flow
- (0)
Latest quarter · Q3 FY2023
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (6)
CuraScientific Corp. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $34,434 | $86,259 | -60.1% | 10-K 2023-04-17 · proof |
| Gross profit | $21,920 | $55,313 | -60.4% | 10-K 2023-04-17 · proof |
| Operating income | -$2.4 million | -$4.8 million | 10-K 2023-04-17 · proof | |
| Net income | -$5.3 million | -$5.9 million | 10-K 2023-04-17 · proof | |
| Cash from operating activities | -$253,710 | -$553,772 | 10-K 2023-04-17 · proof | |
| Free cash flow | -$268,624 | -$559,386 | 10-K 2023-04-17 · proof | |
| Total assets | $1.6 million | $2.2 million | -30.7% | 10-K 2023-04-17 · proof |
| Total liabilities | $71.1 million | $71.6 million | -0.8% | 10-K 2023-04-17 · proof |
| Cash and cash equivalents | $130 | $23,360 | -99.4% | 10-K 2023-04-17 · proof |
- What was CuraScientific Corp.'s revenue in fiscal 2022?
- CuraScientific Corp. reported revenue of $34,434 for fiscal 2022 (the year ended Dec 31, 2022), against $86,259 the year before (-60.1%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What was CuraScientific Corp.'s gross profit in fiscal 2022?
- CuraScientific Corp. reported gross profit of $21,920 for fiscal 2022 (the year ended Dec 31, 2022), against $55,313 the year before (-60.4%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What was CuraScientific Corp.'s operating income in fiscal 2022?
- CuraScientific Corp. reported operating income of -$2.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$4.8 million the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What was CuraScientific Corp.'s net income in fiscal 2022?
- CuraScientific Corp. reported net income of -$5.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$5.9 million the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What was CuraScientific Corp.'s cash from operating activities in fiscal 2022?
- CuraScientific Corp. reported cash from operating activities of -$253,710 for fiscal 2022 (the year ended Dec 31, 2022), against -$553,772 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What was CuraScientific Corp.'s free cash flow in fiscal 2022?
- CuraScientific Corp. reported free cash flow of -$268,624 for fiscal 2022 (the year ended Dec 31, 2022), against -$559,386 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What are CuraScientific Corp.'s total assets?
- As of Dec 31, 2022, CuraScientific Corp. reported total assets of $1.6 million, against $2.2 million a year earlier (-30.7%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What are CuraScientific Corp.'s total liabilities?
- As of Dec 31, 2022, CuraScientific Corp. reported total liabilities of $71.1 million, against $71.6 million a year earlier (-0.8%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What are CuraScientific Corp.'s cash and cash equivalents?
- As of Dec 31, 2022, CuraScientific Corp. reported cash and cash equivalents of $130, against $23,360 a year earlier (-99.4%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1877788&period_type=annual&limit=5"Information only, not investment advice.